Alexandra is Senior Medical Science Liaison at Ultragenyx, a biopharmaceutical company committed to bringing to patients novel products for the treatment of rare diseases. Alexandra has expertise in metabolic bone disease and inborn errors of metabolism. She has supported the launch of therapies for three rare diseases over the past 4 years; Kanuma®, Strensiq® and Crysvita®. She is dedicated to supporting physicians by providing scientific support in academic and healthcare settings.